Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn:
“Hi Friends,
As Assistant Director of the Metastatic Breast Cancer Program at DFCI, we have 3 goals:
- Enhance clinical trial screening for all MBC patients seen at DFCI
- Create a robust, collaborative care model between DFCI and referring providers
- Enhance QOL and satisfaction with care amongst MBC patients through educational programs and supportive care resources.
Help me achieve these goals which are mostly philanthropy covered!”
More posts from S. Sammons.